血紅素結合蛋白當冠狀動脈心臟病之蛋白質體藥評估

Pharmacology, Toxicology and Pharmaceutical Science

1. Haptoglobin 100%
2. Coronary Artery Disease 80%
3. Inflammation 50%
4. Atherosclerosis 30%
5. Nanoparticle 30%
6. Restenosis 20%
7. Combination Therapy 20%
8. Dimer 10%
9. Pharmaceutical Market 10%
10. Fucoidan 10%
11. Wound Healing 10%
12. Antioxidant Capacity 10%
13. Chronic Inflammation 10%
14. Adhesive Agent 10%
15. Ischemic Heart Disease 10%
16. Diseases 10%

Immunology and Microbiology

1. Coronary Artery 100%
2. Atherosclerosis 30%
3. Angiogenesis 20%
4. Signal Transduction 10%
5. Allele 10%
6. Cell Level 10%
7. Capillary 10%
8. Antioxidant Activity 10%
9. Cell Proliferation 10%
10. Macrophage 10%
11. Wound Healing 10%
12. Umbilical Vein Endothelial Cell 10%
13. Cardiac Muscle Cell 10%
14. Blood Vessels 10%
15. Drug Therapy 10%